Early response evaluation by single cell signaling profiling in acute myeloid leukemia
Nature Communication 14, 115 (2023)
Research article: Ex vivo venetoclax sensitivity testing predicts treatment response in acute myeloid leukemia
Haematologica Early view Dec 15, 2022
Research article: Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia
Cancer Discov (2022) 12 (2): 388–401.
The LD-VenEX phase II clinical trial: AN ex vivo flow cytometry based-drug screening of AML patient samples
Workshop and Symposium 2022, 5– 7 . september 2022, Helsinki, Finland